Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Otitis media
ADR ID BADD_A03229
ADR Hierarchy
04      Ear and labyrinth disorders
04.05      Middle ear disorders (excl congenital)
04.05.01      Middle ear infections and inflammations
04.05.01.001      Otitis media
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.05      Ear infections
11.01.05.004      Otitis media
Description A disorder characterized by an infectious process involving the middle ear. [CTCAE] Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. [MeSH]
MedDRA Code 10033078
MeSH ID D010033; D010034
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Bilateral otitis media | Middle ear infection | Non-suppurative otitis media | Nonsuppurative otitis media, not specified as acute or chronic | Otitis media | Otitis media NOS | Otitis media serous | Otitis media serous NOS | Otitis media suppurative | Otitis media suppurative NOS | Secretory otitis media | Suppurative and unspecified otitis media | Unspecified otitis media | Unspecified suppurative otitis media | Catarrh of middle ear | Otitis media recurrent | Otitis media with effusion | Otitis Media | Middle Ear Inflammation | Inflammation, Middle Ear
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02062Sparfloxacin--
BADD_D02078Succimer--
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02147Telmisartan--
BADD_D02150Temozolomide--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02241Tolcapone--
BADD_D02247Topiramate--
BADD_D02254Tramadol--
BADD_D02272Triamcinolone acetonide--
BADD_D02319Urofollitropin--
BADD_D02321Ursodiol--
BADD_D02325Valdecoxib--
BADD_D02329Valproic acid--
BADD_D02346Venlafaxine--
BADD_D02355Vigabatrin--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
The 5th Page    First    Pre   5    Total 5 Pages